Tutorial on survival modeling with applications to omics data

Abstract

Motivation: Identification of genomic, molecular and clinical markers prognostic of patient survival is important for developing personalized disease prevention, diagnostic and treatment approaches. Modern omics technologies have made it possible to investigate the prognostic impact of markers at multiple molecular levels, including genomics, epigenomics, transcriptomics, proteomics and metabolomics, and how these potential risk factors complement clinical characterization of patient outcomes for survival prognosis. However, the massive sizes of the omics data sets, along with their correlation structures, pose challenges for studying relationships between the molecular information and patients' survival outcomes. Results: We present a general workflow for survival analysis that is applicable to high-dimensional omics data as inputs when identifying survival-associated features and validating survival models. In particular, we focus on the commonly used Cox-type penalized regressions and hierarchical Bayesian models for feature selection in survival analysis, which are are especially useful for high-dimensional data, but the framework is applicable more generally. Availability and implementation: A step-by-step R tutorial using The Cancer Genome Atlas survival and omics data for the execution and evaluation of survival models has been made available at https://ocbe-uio.github.io/survomics/survomics.html.

References in corpus (8)

• Optimal predictive model selection
• Time-to-Event Prediction with Neural Networks and Cox Regression
• Deep Learning for Survival Analysis: A Review
• Large-scale benchmark study of survival prediction methods using multi-omics data
• Structured penalized regression for drug sensitivity prediction
• Bayesian Variable Selection for Cox Regression Model with Spatially Varying Coefficients with Applications to Louisiana Respiratory Cancer Data
• Multivariate Bayesian structured variable selection for pharmacogenomic studies
• Survival ensembles by the sum of pairwise differences with application to lung cancer microarray studies

Cited by in corpus (2)

• Optimizing Prognostic Biomarker Discovery in Pancreatic Cancer Through Hybrid Ensemble Feature Selection and Multi-Omics Data
• A Weibull Mixture Cure Frailty Model for High-dimensional Covariates